Search Results 61-70 of 2573 for ☀[광고텔레:SEOGOT] 구글바카라커뮤니티광고 구글백링크광고 유심판매 상단홍보 비아그라광고 백링크홍보☀

  1. A Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy - Mayo Clinic

    The primary purpose of this study is to investigate the long-term safety and tolerability of TAK-935/OV935 as an adjunctive therapy in patients with epileptic ...

  2. The Appropriate Timing of CT Abdomen in Febrile Neutropenic Patient - Mayo Clinic

    About this study. The purpose of this study is to develop a highly sensitive clinical prediction rule to identify patients with neutropenic fever who are at ...

  3. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With ...

  4. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...

  5. Visiting Medical Student Clerkships - Obstetrics and Gynecology, Gynecologic Surgery (Arizona)

    Develop an understanding of the indications for surgical therapy for benign and malignant gynecological disorders. Gain experience dealing with unusual ...

  6. Joseph F. Drazkowski, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Joseph F. Drazkowski, M.D., studies social determinants of health and quality of life issues for patients with epilepsy.

  7. BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. William M. Stone, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher William M. Stone, M.D., is a vascular surgeon with expertise in open and endovascular surgery.

  9. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

    18 years of age or older. · Plan to initiate treatment with either bi-specific antibody or CAR-T therapy either as standard of care or through clinical trial.

  10. Faculty - Mayo Clinic Research

    The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...